Authorized Generics are prescription drugs produced by brand pharmaceutical companies and marketed under a private label, at generic prices. Authorized Generics compete with generic products in that they are identical to their brand counterpart in both active and inactive ingredients^[1]; whereas according to the Office of Generic Drugs, generic drugs must contain identical active ingredients as the brand^[2]. Authorized Generics compete with generics on price, quality and availability in the generic marketplace, and are marketed to consumers during and after what is commonly known as “the 180-day exclusivity period”.

Public Studies

According to Roper Public Affairs & Media, 2005 public research underlines consumer demand to have Authorized Generic prescription drugs availalble, showing over 80 percent of Americans want the option of Authorized Generic prescription drugs ^[3]. The FTC is currently undergoing a study entitled the "Competitive Implications of Authorized Generic Drugs" ^[2] in the marketplace. Several independent organizations have commissioned their own studies including Pharmaceutical Research and Manufacturers of America^[4],^[5] Sonecon^[6][7], GPhA^[8][9], furthering the competitive debate.

[edit] References

[edit] External links

• FDA - Authorized Generics

This pharmacology-related article is a stub. You can help Wikipedia by expanding it. v • d • e

This business-related article is a stub. You can help Wikipedia by expanding it. v • d • e